Article
Polymorphisms of methionine synthase and methionine synthase reductase and risk of lung cancer: a case-control analysis.
Pharmacogenetics and genomics - 1 Aug 2005
Shi Qiuling, Zhang Zhengdong, Li Guojun, Pillow Patricia C, Hernandez Ladia M, Spitz Margaret R, Wei Qingyi
Abstract excerpt
Although tobacco is the major lung cancer risk factor, folate deficiency has also been implicated as a risk. Methionine synthase (MS; gene symbol, MTR) and methionine synthase reductase (MSR; gene symbol, MTRR) play important roles in the folate metabolism pathway. It was hypothesized that polymorphisms of MTR and MTRR are associated with lung cancer risk and interact with dietary intake of folate-related...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
